SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-048825
Filing Date
2020-08-31
Accepted
2020-08-31 17:44:53
Documents
2
Period of Report
2020-08-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1583
2 EX-24 DOCUMENT attachment1.htm EX-24 4284
  Complete submission text file 0001209191-20-048825.txt   7232
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Issuer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 85 WELLS AVENUE SUITE 210 NEWTON MA 02459
Business Address
Oliger Christy J. (Reporting) CIK: 0001822092 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36167 | Film No.: 201152757